Evidence map›Paper›PMID 26719559›Full record

ArticleJournal of virology2016

Correction for Strong et al., Epstein-Barr Virus and Human Herpesvirus 6 Detection in a Non-Hodgkin's Diffuse Large B-Cell Lymphoma Cohort by Using RNA Sequencing.

Michael J Strong, Tina O'Grady, Zhen Lin, Guorong Xu, Melody Baddoo, Chris Parsons, Kun Zhang, Christopher M Taylor, Erik K Flemington

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Tumour virology in the era of high-throughput genomics.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Michael J StrongDepartment of Pathology, Tulane University, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA.
Tina O'GradyDepartment of Pathology, Tulane University, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA.
Zhen LinDepartment of Pathology, Tulane University, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA.
Guorong XuBaylor Institute for Immunology Research, Dallas, Texas, USA.
Melody BaddooDepartment of Pathology, Tulane University, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA.
Chris ParsonsDepartment of Microbiology, Immunology & Parasitology, Louisiana State University School of Medicine, New Orleans, Louisiana, USA.
Kun ZhangDepartment of Computer Science, Xavier University of Louisiana, New Orleans, Louisiana, USA.
Christopher M TaylorDepartment of Microbiology, Immunology & Parasitology, Louisiana State University School of Medicine, New Orleans, Louisiana, USA Research Institute for Children, Children's Hospital, New Orleans, Louisiana, USA.
Erik K FlemingtonDepartment of Pathology, Tulane University, New Orleans, Louisiana, USA Tulane Cancer Center, New Orleans, Louisiana, USA.
Tulane University · USChildren's Hospital of New Orleans · USLouisiana State University Health Sciences Center New Orleans · USXavier University of Louisiana · US

Funding

Xavier's RCMI Cancer Research ProgramG12MD007595 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI D'AMOUR, GENE, WANG, GUANGDI · 2012 to 2018
$15.7M
NIMHD NIH HHS G12 MD007595
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26719559
PMCPMC4702704
OpenAlexW2285247369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.